CLINICAL TRIALS PROFILE FOR NEBCIN
✉ Email this page to a colleague
All Clinical Trials for NEBCIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03066453 ↗ | Evaluation of Short Antibiotic Combination Courses Followed by Aerosols in Cystic Fibrosis | Terminated | University Hospital, Lille | Phase 3 | 2017-06-13 | The aim of this study is to investigate the efficacy of antibiotic therapy with any antibiotic (IV) and IV (Nebcin®) tobramycin for 5 days followed by Solution for nebuliser inhalation (Tobi®) for 9 days and antibiotic cures using 14 days of tobramycin IV. In the case of positive results, the reduction of the duration of IV treatment of tobramycin from 14 days to 5 days would limit the risk of toxicity. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NEBCIN
Condition Name
Clinical Trial Locations for NEBCIN
Clinical Trial Progress for NEBCIN
Clinical Trial Phase
Clinical Trial Sponsors for NEBCIN
Sponsor Name